A 3D bioprinting exemplar of the consequences of the regulatory requirements on customized processes.
暂无分享,去创建一个
David J. Williams | Joel Segal | David J Williams | Nicholas Medcalf | Paul Hourd | J. Segal | N. Medcalf | P. Hourd
[1] Shuyun Liu,et al. The ECM-Cell Interaction of Cartilage Extracellular Matrix on Chondrocytes , 2014, BioMed research international.
[2] J. Ciurana,et al. Biomedical production of implants by additive electro-chemical and physical processes , 2012 .
[3] Anthony Atala,et al. 3D bioprinting of tissues and organs , 2014, Nature Biotechnology.
[4] Yos S. Morsi,et al. Virtual prototyping of biomanufacturing in medical applications: Conventional manufacturing processes for three-dimensional scaffolds , 2007 .
[5] Colleen L Flanagan,et al. Bioresorbable scaffolds for bone tissue engineering: optimal design, fabrication, mechanical testing and scale-size effects analysis. , 2015, Medical engineering & physics.
[6] Pablo Irarrazaval,et al. Sensitivity analysis of geometric errors in additive manufacturing medical models. , 2015, Medical engineering & physics.
[7] C. L. Ventola. Medical Applications for 3D Printing: Current and Projected Uses. , 2014, P & T : a peer-reviewed journal for formulary management.
[8] Jean-Philippe St-Pierre,et al. Tissue engineering and regenerative medicine: a year in review. , 2014, Tissue engineering. Part B, Reviews.
[9] Steven S. Oh,et al. Considerations for tissue-engineered and regenerative medicine product development prior to clinical trials in the United States. , 2010, Tissue engineering. Part B, Reviews.
[10] Scott J Hollister,et al. Scaffold translation: barriers between concept and clinic. , 2011, Tissue engineering. Part B, Reviews.